Press Releases

  • New Release Geneious Biologics Gives Deeper Insight into Big Data

    SAN DIEGO, CA - Dec 11, 2017 - SAN DIEGO, CA – December 11, 2017 – Geneious Biologics, an enterprise software as a service (SaaS) solution used by companies engaged in commercial antibody screening and discovery, today released major new capability that will allow developers of biological drugs to analyze millions of raw antibody sequences in minutes, accelerating identification of therapeutic antibody candidates

    Dec 11, 2017

  • Certara Introduces New Investigator Awards Program in Australia

    PRINCETON, NJ - Dec 8, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, announced that Leigh Farrell, PhD, Vice President of Corporate Strategy and Business Development, is presenting the inaugural Certara New Investigator Awards in association with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)

    Dec 8, 2017

  • Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety and Efficacy in Clinical Trials

    DOYLESTOWN, PA, UNITED STATES - Dec 5, 2017 -  Bioclinica®, the world-leading provider of technology-enabled solutions for clinical research, today announces the launch of Bioclinica Clinical Adjudication, a transformational offering in which medical specialists and researchers, backed by advanced technology, lead independent Clinical Event Committee (CEC) review

    Dec 5, 2017

  • Certara Launches Version 17 of its PBPK Simcyp Simulator

    PRINCETON, NJ - Dec 4, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has launched version 17 of its Simcyp® Population-based Simulator

    Dec 4, 2017

  • ERT Acquires iCardiac Technologies

    PHILADELPHIA, PA, UNITED STATES - Dec 4, 2017 -  ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has acquired iCardiac Technologies, a leading provider of centralized cardiac safety and respiratory solutions that accelerate clinical research

    Dec 4, 2017

  • Tissue Science and Regenerative Medicine

    SYDNEY, AUSTRALIA - Jul 13, 2018 - We are glad to invite you all for 9th International Conference on Tissue Science and Regenerative Medicine

    Nov 29, 2017

  • RxTE Health Appoints Senior Vice President of Clinical Operations

    SILICON VALLEY, CA, UNITED STATES - Nov 28, 2017 - RxTE Health (RxTE), a company specializing in pharmacy cost reduction programs for employers, today announced that it has expanded its executive team with the addition of Sara Linnerooth, PharmD, as Senior Vice President of Clinical Operations

    Nov 28, 2017

  • WIRB-Copernicus Group Acquires Vigilare International

    PRINCETON, NJ - Nov 28, 2017 - WIRB Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of Vigilare International, the top provider of integrated, end-to-end pharmacovigilance and drug safety solutions for the biopharmaceutical and biotech industry

    Nov 28, 2017

  • BioIVT Introduces New Products and Services to Improve Safety, Efficacy and Toxicity Testing for Skin Care Products, Cosmetics and Topical Medications

    WESTBURY, NY - Nov 27, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it is launching a new line of products and services to improve safety, efficacy and toxicity testing for skin care products, cosmetics and topical medications

    Nov 27, 2017

  • Vanessa Research starts Phase 2 clinical trials in early 2018 for Shylicine™

    HAMDEN, CT, UNITED STATES - Nov 15, 2017 - Vanessa Research, Inc. (VRI), an emerging healthcare and biotech company, attended its first meeting with the European Medicines Agency in October and will now start its Phase 2 clinical trials in the first quarter of 2018 for the rare disease Microvillus Inclusion Disease (MVID)

    Nov 16, 2017

  • WIRB-Copernicus Group Partners with Veeva Systems Inc.

    PRINCETON, NJ - Nov 16, 2017 - WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that it is partnering with Veeva Systems Inc

    Nov 16, 2017

  • FDA Renews and Expands its Portfolio of Simcyp Simulator (PBPK) Licenses

    PRINCETON, NJ - Nov 14, 2017 - Certara®, the global leader in model-informed drug development and regulatory science, today announced that the US Food and Drug Administration (FDA) has greatly expanded its use of Certara’s PBPK Simcyp® Population-based Simulator and its Pediatric and Cardiac Safety Simulators

    Nov 14, 2017

  • RxTE Health Promotes David Henka to Chief Executive Officer

    SILICON VALLEY, CA, UNITED STATES - Nov 7, 2017 - RxTE Health (RxTE), a company specializing in pharmacy cost reduction programs for employers, today announced that its president, David Henka, has been promoted to Chief Executive Officer

    Nov 7, 2017

  • BioIVT to Present Advances in Immunohistochemistry at AAPS Annual Meeting

    WESTBURY, NY - Nov 7, 2017 - BioIVT, a leading provider of biospecimens and related services, today announced that it will be presenting and exhibiting at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting

    Nov 7, 2017

  • Bioclinica Acquires MDDX Research & Informatics Combining Advanced Image Management Cloud Technology with Its Scientific and Medical Imaging Leadership

    AUDUBON, PA, UNITED STATES - Nov 6, 2017 - Bioclinica®, the world-leading provider of scientific-enabled Medical Imaging, eHealth, and patient-centric solutions supporting clinical research, today announces it has acquired Silicon Valley-based MDDX Research & Informatics, adding the industry’s most advanced cloud research image management and submission technologies to its extensive suite of eHealth solutions

    Nov 6, 2017

  • ERT Recognized for Excellence in Patient Centricity

    PHILADELPHIA, PA, UNITED STATES - Nov 1, 2017 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced it has been recognized with a CPhI Pharma Award for Excellence in Patient Centricity

    Nov 1, 2017

  • Rho to Bring Clinical Trial Proficiency to Multiple Conferences in November

    DURHAM, NC, UNITED STATES - Oct 31, 2017 - What:                  Rho, a full-service contract research organization (CRO), will showcase its clinical trial expertise at three upcoming conferences: TEDMED, North American Cystic Fibrosis Conference (NACFC), and Human Abuse Liability & Abuse-Deterrent Formulation (HAL)

    Oct 31, 2017

  • Tech savvy ‘crucial’ to advancement in STEM careers, according to survey(1)

    - Oct 30, 2017 - Being tech savvy is critical to career advancement prospects for chemists, according to a survey of 186 chemistry professionals from industry and academia, carried out by Elsevier’s Reaxys team

    Oct 30, 2017

  • Certara-Monash University Industry Fellowship Program Receives Funding from MTPConnect’s Project Fund Program

    MELBOURNE, AUSTRALIA - Oct 26, 2017 - MTPConnect - the Medical Technologies and Pharmaceuticals Industry Growth Centre - today announced it will provide a proposed AUD750,000 provisional funding to the Certara-Monash University Industry Fellowship Program over two years, with proposed matched funding of AUD750,000 coming from Certara®

    Oct 26, 2017

  • Elsevier announces winners of the 2017 Reaxys PhD Prize

    SHANGHAI - Oct 25, 2017 - Elsevier, the information analytics business specializing in science and health, announced the three winners of the 2017 Reaxys PhD Prize at its annual Symposium held in Shanghai, China

    Oct 25, 2017